Picture of Cardiff Oncology logo

CRDF — Cardiff Oncology News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Cardiff Oncology Inc reports results for the quarter ended in June - Earnings Summary

* Cardiff Oncology Inc  CRDF.OQ  reported a quarterly
adjusted
loss of 26 cents​​ per share for the quarter ended in June,
lower than the same quarter last year, when the company reported
EPS of -25 cents.  The mean expectation of four analysts for the
quarter was for a loss of 25 cents per share. Wall Street
expected results to range from -26 cents to -24 cents per share.
    * Revenue rose 50.9% to $163.00 thousand from a year ago;
analysts
expected $58.75 thousand. 
    * Cardiff Oncology Inc's reported EPS for the quarter was a
loss
of 26 cents​.
    * The company reported a quarterly loss of $11.78 million.
    * Cardiff Oncology Inc shares had fallen by 3.6% this
quarter and
gained 44.6% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Cardiff Oncology
Inc is $10.50 
This summary was machine generated from LSEG data August 8 at
10:13 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -0.25          -0.26          Missed
 Mar. 31 2024      -0.25          -0.22          Beat
 Dec. 31 2023      -0.28          -0.21          Beat
 Sep. 30 2023      -0.28          -0.22          Beat

Recent news on Cardiff Oncology

See all news